Meihua International Medical Technologies Co., Ltd. (MHUAF)
OTCMKTS · Delayed Price · Currency is USD
8.45
+0.05 (0.60%)
At close: Jun 2, 2026
MHUAF Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 9.27 | 10.84 | 11.59 | 6.18 | 20.95 | 19.05 |
Depreciation & Amortization | 0.55 | 0.57 | 0.47 | 0.56 | 0.62 | 0.52 |
Other Adjustments | 2.26 | 3.26 | 1.81 | 4.51 | 0.02 | 0 |
Change in Receivables | -5.66 | -3.21 | -12.99 | -11.41 | -26.6 | -19.41 |
Changes in Inventories | 0.01 | 0.17 | -0.53 | 0.04 | 0.11 | -0.22 |
Changes in Accounts Payable | -4.6 | 0.93 | 0.19 | -3.37 | 4.91 | 5.34 |
Changes in Accrued Expenses | -0.05 | 0.6 | 0.01 | 0.08 | 0.12 | 0.1 |
Changes in Income Taxes Payable | -0.43 | 0.19 | -0.02 | -0.81 | 0.29 | 0.6 |
Changes in Other Operating Activities | 1.22 | 1.3 | 1.74 | -4.93 | -0.47 | -0.66 |
Operating Cash Flow | 3.72 | 14.64 | 2.28 | -9.16 | -0.05 | 5.33 |
Operating Cash Flow Growth | 12.98% | 543.16% | - | - | - | -42.78% |
Capital Expenditures | -0.13 | -0.13 | -1.18 | -2.7 | -0.85 | -3.81 |
Sale of Property, Plant & Equipment | - | - | 0.35 | 0.02 | 0.02 | 0.03 |
Purchases of Intangible Assets | - | - | -3.5 | - | - | - |
Purchases of Investments | - | -4.86 | - | -5.94 | - | - |
Proceeds from Sale of Investments | - | 0.57 | 0.35 | - | - | - |
Other Investing Activities | -12.68 | -15.99 | -8.47 | - | - | -12.31 |
Investing Cash Flow | -8.91 | -20.42 | -12.46 | -8.62 | -0.83 | -16.09 |
Short-Term Debt Issued | 15.91 | 10.56 | 6.64 | 7.58 | 6.51 | 4.36 |
Short-Term Debt Repaid | -12.32 | -9.73 | -5.93 | - | -4.65 | -3.93 |
Net Short-Term Debt Issued (Repaid) | 3.59 | 0.83 | 0.71 | 7.58 | 1.86 | 0.43 |
Long-Term Debt Issued | - | 5.58 | - | 0.64 | - | - |
Net Long-Term Debt Issued (Repaid) | - | 5.58 | - | 0.64 | - | - |
Issuance of Common Stock | - | - | - | 34.53 | - | 1.27 |
Repurchase of Common Stock | - | -0.2 | - | 0.74 | - | - |
Net Common Stock Issued (Repurchased) | - | -0.2 | - | 35.27 | - | 1.27 |
Financing Cash Flow | 3.39 | 6.21 | 0.71 | 37.25 | 1.86 | 1.71 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 0.21 | -0.07 | -0.33 | -0.87 | -0.01 | 0.22 |
Net Cash Flow | -1.59 | 0.36 | -9.81 | 18.59 | 0.96 | -8.84 |
Beginning Cash & Cash Equivalents | - | 16.93 | 26.74 | 8.15 | 7.19 | 16.03 |
Ending Cash & Cash Equivalents | -1.59 | 17.29 | 16.93 | 26.74 | 8.15 | 7.19 |
Free Cash Flow | 3.59 | 14.5 | 1.09 | -11.86 | -0.9 | 1.52 |
Free Cash Flow Growth | -75.28% | 1226.86% | - | - | - | -83.21% |
FCF Margin | 4.00% | 14.97% | 1.13% | -11.48% | -0.87% | 1.70% |
Free Cash Flow Per Share | - | 0.45 | 0.03 | -0.40 | -0.03 | 0.13 |
Levered Free Cash Flow | 9.42 | 20.88 | 13.01 | 3.32 | 27.54 | 21.36 |
Unlevered Free Cash Flow | 5.92 | 15.01 | 11.98 | -5.01 | 25.71 | 20.71 |